Why the study?
Pre-participation cardiovascular screening aims to reduce sudden cardiac arrest in athletes, but sudden cardiac arrest can still occur shortly after screening without alarming findings.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Pre-participation cardiovascular screening cannot guarantee absolute safety from sudden cardiac arrest in athletes, as new diseases and risk factors can emerge.
One of the solutions to decrease the frequency of sudden cardiac arrest (SCA) in athletes is cardiovascular screening in the form of pre-participation tests (PPT). It is especially frustrating when SCA affects an athlete who has recently undergone PPT without any alarming findings. In our case, a 44-year-old ambitious amateur duathlete who underwent PPT within a year experienced SCA at home after an intensive weekend of training. It was related to a coincidence of new disease and other risk factors. PPT cannot be viewed as an unconditional green light for training and competition.
No takes yet. Share an insight, caveat, or question.
Małek et al. (2025) conducted a case report in Sudden cardiac arrest, hypertrophic obstructive cardiomyopathy (n=1). Subcutaneous implantable cardioverter defibrillator (S-ICD) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: